PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 220.00
Bid: 218.50
Ask: 219.50
Change: -2.00 (-0.90%)
Spread: 1.00 (0.458%)
Open: 218.50
High: 224.50
Low: 217.00
Prev. Close: 222.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Billington faces headwinds; Immotion plans spin-off

Tue, 26th Apr 2022 18:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Immotion Group PLC - Manchester, England-based virtual reality entertainment company - Revenue for 2021 rises to GBP9.4 million from GBP2.8 million in 2020, with pretax loss narrowing to GBP2.0 million from GBP4.8 million. Says second half of year was one of "recovery and progress", particularly for Location Based Entertainment business, at a "much faster rate" than anticipated. "This, particularly in the United States, boosted our confidence in the potential of this part of our business as illustrated by very strong revenue and contribution growth to match," it says. This made it reconsider strategy for other two businesses, HBE and Uvisan, and concludes it needs to focus resources on LBE which has a strong pipeline. "We therefore intend to spin out HBE and Uvisan in the short term to enable us to be fully focused on LBE as we are confident that this compelling business model is highly scalable and can drive superior shareholder returns," it says.

----------

Billington Holdings PLC - Barnsley, England-based construction company - Revenue for 2021 rises 25% to GBP82.7 million from GBP66.0 million in 2020, but pretax profit drops 88% to GBP179,000 from GBP1.7 million. Says activity levels improved following the peak of the pandemic shutdowns experienced in 2020 and firm remained profitable in "challenging" market conditions. "2021 was a year of partial recovery for our markets as the worst effects of the Covid-19 pandemic abated. However, the group continued to face challenges from the continuing impact of the Covid-19 pandemic, raw material price increases, together with supply constraints for certain materials and labour," says Chief Executive Mark Smith. Dividend cut to 3.00 pence from 4.25p.

----------

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Revenue in 2021 amounts to USD17.4 million, up from USD11.8 million in 2020. Swings to pretax loss of USD59.0 million from profit of USD19.0 million in 2020, largely due to USD73.7 million share of net loss of associates accounted for using the equity method. Consolidated cash and cash equivalents stand at USD465.7 million at the end of December, easing to USD413.2 million at end of March, 2022. Spend largely attributed to the successful progression of wholly owned programs into more advanced stages of development. "Based on the strong foundation we have built to support PureTech's future growth, our Board and senior leadership team have been considering various approaches to drive additional value for our shareholders, including reviewing a capital allocation strategy that balances investment in the continued growth of our business with potential returns of capital to shareholders," says Founder & Chief Executive Officer Daphne Zohar.

----------

Focusrite PLC - High Wycombe, Buckinghamshire-based music and audio products company - Revenue for half-year to February 28 falls to GBP92.9 million from GBP95.3 million a year before. While revenue declines year-on-year, it remains well above pre-pandemic levels of GBP49.9 million. Pretax profit declines to GBP16.5 million from GBP23.6 million. "Demand for the group's portfolio of products has remained strong, and the group's overall performance in the half year was in line with our expectations and remains on track for the full year. As anticipated, demand and sales volumes for home creation solutions has tapered off from the unprecedented high levels during the peak of lockdown but remain materially ahead of pre pandemic levels," it says. Notes short-term downward pressure on gross margin from shortage of electronic components and high freight costs. Says outlook for industry remains positive and firm is on track to meet expectations for the full year. Interim dividend for period rises to 1.85p from 1.5p.

----------

Gaming Realms PLC - London-based developer and licensor of mobile focused gaming content - Revenue rises 29% to GBP14.7 million in 2021 from GBP11.4 million in 2020. Swings to pretax profit of GBP957,716 from loss of GBP1.6 million the year before. Says results "reflect the continued delivery of the core strategy of scaling the licensing business." Adds that momentum has continued in 2022, with Gaming Realms focusing on regulated markets and North America in particular. "The company has made an excellent start to the current year, with licensing revenues increasing by 43% year-on-year for the first quarter of 2022, and unique players increasing by 39% to over 1.5 million in the same period. This strong performance in the first quarter, combined with new markets and partners coming on stream, leads your board to believe the company will continue to grow significantly following its proven successful strategy," it says.

----------

Dillistone Group PLC - Basingstoke, England-based software and services provider that enables recruitment firms to manage their selection process - Says performance in 2021 was ahead of expectations, even as revenue falls to GBP5.6 million from GBP6.3 million, though pretax loss slims to GBP298,000 from GBP914,000. Firm reduces administrative expenses to GBP5.1 million from GBP6.6 million. "In my interim statement I highlighted that in our business, where a large part of our revenue is contracted annually in advance, the impact of Covid would be felt throughout the remainder of 2021. This proved to be the case, however we saw an uplift in orders in Q4 2021 to pre-pandemic levels," firm says. Says the current year has started well following a "strong finish" in 2021. Incoming orders in the first quarter of 2022 are up by 41%, and company says it is trading in line with expectations and does not expect to raise additional funds.

Separately, Dillistone says Chief Financial Officer Joanne Curd, who was appointed in 2021 on a part time basis, is leaving and will be replaced by Financial Controller Ian Mackin as interim finance director on a full-time basis from June 16.

----------

Warpaint London PLC - Buckinghamshire-based cosmetics maker - Revenue for 2021 rises to GBP50.0 million from GBP40.3 million in 2020, with firm swinging to pretax profit of GBP3.7 million from loss of GBP1.1 million the year before. "In 2021 we enjoyed a return to growth, with sales and profits exceeding those achieved in 2019, the last full period before the pandemic struck. During the year we focused on increasing our presence in larger retailers globally, through expanding existing relationships and developing new ones," firm says. Total dividend for year lifted to 6.0p from 5.8p in 2020. On start to 2022, firm says: "In the first quarter of 2022 we have enjoyed further profitable growth as we focus on supplying additional retailers and growing sales through our existing customers, taking more warehouse space and adding further stores."

----------

Futura Medical PLC - Guildford, England-based pharmaceutical firm - Pretax loss in 2021 widens to GBP5.9 million from GBP2.9 million in 2020, with no revenue generated in either year. "2021 has been a year of transformational progress and momentum for Futura as the Company achieved major milestones in terms of first regulatory approval for our lead product, MED3000, as an approved erectile dysfunction treatment and completion of a number of commercial MED3000 licensing deals as we continue to build a global distribution platform," it says. Adds that current cash runway extends beyond initial MED3000 launches expected over the next year and expected US regulatory approval in 2023, assuming no contributions from milestone payments or other revenue.

----------

Afentra PLC - upstream operator in Africa with carried interest in Odewayne block onshore southwestern Somaliland - Pretax loss for 2021 widens to USD5.0 million from USD1.9 million in 2020. No revenue recorded in either year. Widened loss follows increase in total administrative expenses. "It has been an active period for your company and we expect momentum to accelerate through 2022 as we strive to deliver our first value accretive transaction for our shareholders," firm says. Adds it remains debt free and fully carried for Odewayne operations.

----------

Light Science Technologies Holdings PLC - environment agriculture and technology and contract electronics manufacturing company - Reports revenue of GBP7.4 million for financial year to November 30, up from GBP6.9 million the year before, but firm swings to pretax loss of GBP2.3 million from profit of GBP147,995. Firm notes loss reflects cost of the AIM admission process and investment in CEA division. "With the large part of this financial year being pre-IPO, the main focus for Light Science Technologies was to develop its new market CEA products, IP collateral, and build its brand and a robust sales pipeline," it says. Notes headwinds such as Ukraine, Brexit, high energy costs and global electronic component shortages.

----------

ASA International Group PLC - Weybridge, Surrey-based microfinance lender - Total operating income for 2021 USD120.3 million, up from USD84.9 million in 2020. Pretax profit multiples to USD25.7 million from USD2.6 million. "I am particularly pleased that all but two of our major operating subsidiaries recovered to or exceeded pre-Covid operating and financial performance in 2021. Despite the ongoing challenges we face in India and Myanmar, the performance of most of our other operating countries, including, particularly, Ghana, Pakistan and Tanzania, was excellent in terms of portfolio quality, growth and profitability," says Chief Executive Dirk Brouwer. Company expects operating and financial performance should "substantially" improve in 2022.

----------

United Oil & Gas PLC - London-based oil and gas company with projects in Egypt, Italy and the UK - Revenue for 2021 jumps to USD19.2 million from USD9.1 million in 2020, with pretax profit surging to USD5.9 million from USD796,181. Group working interest 2021 production averaged 2,327 barrels of oil equivalent per day, up from 2,195 boepd in 2020. Realised oil price jumps to USD68.9 per barrel from USD37.8. Group working interest production in Egypt for 2022 is forecast to average between 1,500 and 1,650 boepd net.

----------

Corero Network Security PLC - Buckinghamshire, England-based distributed denial of service cyber defense - Revenue in 2021 rises to USD20.9 million from USD16.8 million in 2020, and firm swings to maiden pretax profit of USD1.4 million from loss of USD4.0 million. Gross margins improve to 85% from 77%. "The strong performance reflects the successful implementation of our growth strategy, with the group delivering continued sales momentum across our operational footprint," company says.

----------

Midatech Pharma PLC - Cardiff-based drug delivery technology company - Pretax loss for 2021 totals GBP6.1 million, narrowed from GBP23.5 million in 2020. This is on revenue that rises to GBP578,000 from GBP180,000. Takes no impairment in the year, versus charge of GBP12.4 million in 2020. "The directors are evaluating a number of near-term funding options potentially available to the group, including fundraising and the partnering of assets and technologies of the company," it says.

----------

Arrow Exploration Corp - Calgary, Canada-based oil and gas company - Total natural gas and crude oil revenue for 2021 rises to USD6.5 million from USD5.3 million the year before, with firm turning to net income of USD5.7 million from a loss of USD32.2 million. The company's fourth quarter average corporate production was 712 barrels of oil equivalent per day, an increase of 137 barrels a day compared to the third quarter. "The increase in production quarter-over-quarter was largely attributable to the Canadian operation following the tie-in of the West Pepper well in Alberta, Canada which was brought into production in December 2021," it says.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 Jul 2022 19:15

TRADING UPDATES: BlueRock hit by extreme weather; Harbour drills well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jun 2022 21:50

IN BRIEF: PureTech Health begins pulmonary fibrosis study

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Begins late-stage clinical study of its wholly-owned candidate LYT-100, or deupirfenidone, in idiopathic pulmonary fibrosis. Will evaluate efficacy of two doses, as well as relative tolerability and efficacy with pirfenidone. IPF is a chronic condition causing progressive scarring of the lungs, which currently has a poor prognosis. Also advances LYT-200 programme through clinical development, and plans to begin leukemia study by the end of 2022.

Read more
28 Jun 2022 14:45

IN BRIEF: PureTech Health's founded firm Vedanta launches new facility

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Announces that its founded firm Entity Vedanta Biosciences Inc launches a new manufacturing facility. The facility will "provide clinical and commercial supply of oral therapies" for people infected with a diarrhoea-causing bacteria, firm says.

Read more
21 Jun 2022 14:24

IN BRIEF: PureTech Health's Gelesis wins USD15 million Plenity order

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Investee Gelesis Holdings Inc receives another USD15 million pre-order for its weight management aid product Plenity from its distribution partner, New-York based telehealth firm Ro. It brings the total orders from Ro to USD55 million, out of which USD45 million was ordered in the last 12 months, PureTech Health adds.

Read more
14 Jun 2022 16:54

IN BRIEF: PureTech achieves availability milestone for LYT-300 study

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Announces results from phase two study of LYT-100-COV on patients with post acute or long Covid with respiratory complications.

Read more
14 Jun 2022 07:33

PureTech reports 'Glyph' milestone, disappointing long Covid results

(Sharecast News) - PureTech Health said on Tuesday that it had met a milestone in proving its 'Glyph' therapeutic platform, while separately announcing disappointing results from a study into long Covid.

Read more
1 Jun 2022 18:21

TOP NEWS: Centrica warms up for FTSE 100 as Royal Mail sent packing

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, June 20 after completing its quarterly review.

Read more
25 May 2022 10:18

Centrica and Johnson Matthey indicated to join FTSE 100, Asos in 250

(Alliance News) - British Gas-owner Centrica PLC and chemical firm Johnson Matthey PLC are set to return to the FTSE 100 index next month, replacing television broadcaster ITV PLC and postal operator Royal Mail PLC, according to indicative changes released by FTSE Russell on Tuesday.

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 11:18

IN BRIEF: PureTech shares rise as unveils USD50 million share buyback

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Approves share buyback of up to USD50 million. Programme follows "follows consultation with shareholders and is consistent with PureTech's capital allocation strategy and stated approach to drive additional value for its shareholders," company says. PureTech says it had USD413.2 million of net cash and cash equivalents at March 31. Given size of balance sheet, PureTech is confident it can return capital to shareholders and also maintain "sufficient cash on hand to deliver" on strategic priorities.

Read more
5 May 2022 10:09

PureTech to buy back up to $50m of shares

(Sharecast News) - PureTech Health has announced a $50m share buyback programme, sending shares in the FTSE 250 biotech sharply higher.

Read more
4 May 2022 13:35

PureTech entity Gelesis reports positive data for weight loss drug

(Alliance News) - Boston-based biotechnology company PureTech Health PLC's founded entity Gelesis Holdings Inc said on Wednesday that its weight loss drug showed positive responses in adults in clinical trials.

Read more
27 Apr 2022 09:42

LONDON BROKER RATINGS: Bank of America cuts Melrose, raises Spectris

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Apr 2022 16:02

UK earnings, trading statements calendar - next 7 days

Wednesday 20 April  
888 Holdings PLCTrading Statement
Bunzl PLCTrading Statement
Carr's Group PLCHalf Year Results
Centamin PLCTrading Statement
Hunting PLCTrading Statement
IntegraFin Holdings PLCTrading Statement
John Wood Group PLCFull Year Results
Oxford Biomedica PLCFull Year Results
Petra Diamonds LtdTrading Statement
Quilter PLCTrading Statement
Thursday 21 April 
AJ Bell PLCTrading Statement
Anglo American PLCTrading Statement
Antofagasta PLCTrading Statement
Bonhill Group PLCFull Year Results
Churchill China PLCFull Year Results
DP Poland PLCTrading Statement
essensys PLCHalf Year Results
Foxtons Group PLCTrading Statement
Gem Diamonds LtdTrading Statement
LBG Media PLCFull Year Results
Man Group PLCTrading Statement
PensionBee Group PLCQ1 Results
Relx PLCTrading Statement
Rentokil Initial PLCTrading Statement
Serica Energy PLCFull Year Results
XPS Pensions Group PLCTrading Statement
Friday 22 April 
Alphawave IP Group PLCFull Year Results
Petropavlovsk PLCTrading Statement
Record PLCTrading Statement
Serabi Gold PLCFull Year Results
Zinc Media Group PLCFull Year Results
Monday 25 April 
Access Intelligence PLCFull Year Results
Arecor Therapeutics PLCFull Year Results
Audioboom Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Chapel Down Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Vector Capital PLCFull Year Results
Tuesday 26 April 
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Billington Holdings PLCFull Year Results
Corero Network Security PLCFull Year Results
Focusrite PLCHalf Year Results
Futura Medical PLCFull Year Results
Gaming Realms PLCFull Year Results
Hochschild Mining PLCTrading Statement
HSBC Holdings PLCQ1 Results (at 0500 BST)
Immotion Group PLCFull Year Results
IWG PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Learning Technologies Group PLCFull Year Results
National Express Group PLCTrading Statement
Northcoders Group PLCFull Year Results
Nostrum Oil & Gas PLCFull Year Results
PureTech Health PLCFull Year Results
RWS Holdings PLCHalf Year Results
Taylor Wimpey PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.